Pharmafile Logo
Pharmafocus logo
Advanced Search

EMIG

Showing 9 posts of 9 posts found.

Confronting the ‘danger’ of blocking progress on clinical trial transparency

August 19, 2015
Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

The Ethical Medicines Industry Group and Sense About Science – a co-founder of the ALLTrials campaign – have written a …

Feature

HRA must continue ‘progress towards clinical trial transparency’

August 19, 2015
Research and Development EMIG, Ethical Medicines Industry Group, Richmond Pharmacology, clinical trial registration, clinical trial transparency, health research authority, hra, sense about science, transparency

Campaigners and industry leaders have urged the Health Research Authority to ensure that its work to bring about full transparency …

News
Sense About Science

Ruling in transparency case ‘due within days’

July 17, 2015
Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …

News
doh image

NICE rejects ‘benefit’ test

January 28, 2014
Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …

News
NHS image

PPRS deal ‘dreadful’, says EMIG

November 26, 2013
Sales and Marketing EMIG, NHS, NICE, PPRS, VBP

The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …

News
NICE image

NICE to assess drug value

March 22, 2013
Sales and Marketing EMIG, NHS, NICE, VBP

NICE will be responsible for assessing the full value of medicines – taking into account their benefit to patients and …

News

VBP negotiations ‘opened up’

February 19, 2013
Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP

Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …

News

Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG

January 19, 2011
Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing

The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …

News

Generic substitution will not deliver significant NHS savings, says EMIG

March 31, 2010
Sales and Marketing EMIG, NHS, generics

The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …

News

Latest content

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023

Teva Pharmaceuticals shares phase 3 data for Ajovy as migraine treatment

December 6, 2023

British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing

December 5, 2023

Genentech shares positive results from phase 3 trial for breast cancer treatment

December 5, 2023

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023